Both protocols typically produce sleep improvements first, often within 1 to 2 weeks
Based on current phase 3 TRIUMPH trial timelines, a regulatory submission to the MHRA is not anticipated before 20262027 at the earliest, with a possible marketing authorisation in 20272028 and NHS availability potentially from 2028 onwards, subject to NICE appraisal
LUPKIN: And this was all legal-- the manufacturing, the compounding, the telehealth companies getting it to customers
Mechanistically, GLP-1 agonists enhance insulin secretion after meals, slow gastric emptying, and suppress glucagon releaseall of which contribute to better glycemic control and weight management
If PCD remains undiagnosed, or if it isnt managed well, serious complications could arise